JA WP5 - Relative Effectiveness Assessment of Pharmaceuticals

WP5 Factsheet

WP5 Objective:

Title

Description

Indicators

Development of HTA tools and methods for Relative Effectiveness of Pharmaceuticals )REA);

Application and field testing of developed tools and methods

To develop principles, methodological guidance as well as functional online tools and policies for REA by identifying areas where methodological guidance is needed and by providing it, suggesting ways to integrate REA of pharmaceuticals as a special version of the Core Model. In addition to test and implement a REA of (a group) of pharmaceuticals in line with the core HTA development.

Outcome indicator:

1. Recommendations on the Assessment of Relative Effectiveness identified and published

Target: Publication of the recommendations in an international journal (submitted).

WP5 Deliverables:

Number (in Grant Agreement)	Title	Description	Confidentiality level	Month of delivery
3	A methodological guidance that will be appropiate for the assessment of relative effectiveness of pharmaceuticals	A common methodology for the relative effectiveness assessment (REA) of pharmaceuticals consisting of a tutorial that describes the fundamental principles of REA and a toolbox that can be used in daily practice for REA in standardized fashion.	Public	December 2012
10	A relative effectiveness assessment of a (group) of pharmaceutical(s)	As a part of methodological guidance development and in line with the Core HTA development.	Public	March 2012